| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 9.99% | 0% | $15,056,434 | -$655,031 | 4,632,749 | -4.2% | BVF PARTNERS L P/IL | 31 Mar 2025 |
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | $14,835,818 | 4,564,867 | RA Capital Management, L.P. | 31 Dec 2024 | |||
| GOLDMAN SACHS GROUP INC | 9.6% | $14,376,165 | 4,423,435 | THE GOLDMAN SACHS GROUP, INC. | 31 Dec 2024 | |||
| Novo Holdings A/S | 6.8% | $27,590,750 | 3,175,000 | Novo Holdings A/S | 13 Oct 2025 | |||
| BlackRock, Inc. | 6.6% | -15% | $26,613,959 | -$4,803,137 | 3,062,596 | -15.3% | BlackRock, Inc. | 30 Sep 2025 |
| JANUS HENDERSON GROUP PLC | 4.9% | $7,319,780 | 2,252,240 | JANUS HENDERSON GROUP PLC | 31 Dec 2024 | |||
| Venrock Healthcare Capital Partners III, L.P. | 1.5% | -81.7% | $2,202,200 | -$7,393,006 | 677,600 | -77% | Venrock Healthcare Capital Partners III, L.P. | 31 Mar 2025 |
| Deep Track Capital, LP | 1.32% | $1,982,175 | 609,900 | Deep Track Capital, LP | 31 Dec 2024 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 39,480,310 | $343,063,021 | -$4,202,043 | $8.69 | 128 |
| 2025 Q2 | 40,369,426 | $149,859,289 | -$9,235,482 | $3.71 | 117 |
| 2025 Q1 | 43,058,381 | $139,823,044 | -$22,403,324 | $3.23 | 122 |
| 2024 Q4 | 46,814,824 | $260,642,119 | -$79,332,651 | $5.57 | 140 |
| 2024 Q3 | 57,948,767 | $626,374,639 | -$34,446,524 | $10.81 | 135 |
| 2024 Q2 | 57,307,189 | $1,203,018,791 | +$3,520,347 | $20.99 | 138 |
| 2024 Q1 | 56,228,706 | $1,790,823,856 | +$449,592,828 | $31.86 | 146 |
| 2023 Q4 | 42,433,937 | $859,819,319 | +$24,792,782 | $20.26 | 111 |
| 2023 Q3 | 41,913,779 | $533,559,212 | +$5,221,810 | $12.73 | 110 |
| 2023 Q2 | 41,248,927 | $745,334,512 | +$197,052,931 | $18.07 | 100 |
| 2023 Q1 | 30,404,028 | $522,337,328 | +$34,968,755 | $17.19 | 94 |
| 2022 Q4 | 28,011,571 | $622,110,124 | +$47,681,640 | $22.21 | 97 |
| 2022 Q3 | 26,181,987 | $210,496,945 | +$1,974,268 | $8.04 | 84 |
| 2022 Q2 | 26,027,061 | $181,670,139 | -$2,172,042 | $6.98 | 86 |
| 2022 Q1 | 26,134,053 | $395,189,957 | +$20,420,485 | $15.12 | 76 |
| 2021 Q4 | 24,702,968 | $541,790,297 | +$81,054,878 | $21.94 | 77 |
| 2021 Q3 | 18,711,908 | $504,667,012 | +$57,523,278 | $26.97 | 61 |
| 2021 Q2 | 16,612,608 | $400,026,000 | +$731,531 | $24.08 | 54 |
| 2021 Q1 | 15,384,514 | $664,816,567 | +$34,097,345 | $43.38 | 63 |
| 2020 Q4 | 14,593,004 | $602,432,000 | +$578,482,000 | $41.45 | 51 |